MX2012004635A - Composicion para inducir regeneracion de tejido mediante activacion de plasma rico en plaquetas (prp), y metodo para fabricar la misma. - Google Patents

Composicion para inducir regeneracion de tejido mediante activacion de plasma rico en plaquetas (prp), y metodo para fabricar la misma.

Info

Publication number
MX2012004635A
MX2012004635A MX2012004635A MX2012004635A MX2012004635A MX 2012004635 A MX2012004635 A MX 2012004635A MX 2012004635 A MX2012004635 A MX 2012004635A MX 2012004635 A MX2012004635 A MX 2012004635A MX 2012004635 A MX2012004635 A MX 2012004635A
Authority
MX
Mexico
Prior art keywords
prp
tissue regeneration
present
composition
rich plasma
Prior art date
Application number
MX2012004635A
Other languages
English (en)
Inventor
Hyun-Shin Park
Jae-Deog Jang
Sae-Bom Lee
Hun Kim
Ji-Chul Yu
Jang-Hoon Kim
Cheong-Ho Jang
Ju-Hee Park
Original Assignee
Sewon Cellontech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sewon Cellontech Co Ltd filed Critical Sewon Cellontech Co Ltd
Publication of MX2012004635A publication Critical patent/MX2012004635A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3616—Blood, e.g. platelet-rich plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)

Abstract

Se describe una composición para inducir regeneración de tejido al activar plasma rico en plaquetas (PRP) con una solución de cloruro de calcio y colágeno tipo I, y un método para fabricar la misma. El método descrito incluye las etapas de: separar PRP de sangre entera; mezclar PRP con una solución de cloruro de calcio; y formar la mezcla de PRP y la solución de cloruro de calcio con colágeno tipo I. La composición descrita puede tener una formación de tipo gel que contiene PRP, y puede trasplantarse a cualquier lesión que requiera regeneración de tejido en casos tales como tratamiento de defectos óseos y sanado de heridas, y de acuerdo con esto PRP puede activarse para inducir un factor de crecimiento que es útil para regeneración de tejido de gel PRP, pata lograr en forma conveniente y rápida regeneración de tejido efectiva. De acuerdo con esto, el método descrito es muy útil para mejorar la credibilidad de aplicar PRP a lesiones y presentar una buena imagen a los consumidores.
MX2012004635A 2009-10-23 2009-11-17 Composicion para inducir regeneracion de tejido mediante activacion de plasma rico en plaquetas (prp), y metodo para fabricar la misma. MX2012004635A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020090101387A KR101114712B1 (ko) 2009-10-23 2009-10-23 염화칼슘용액과 제1형 콜라겐으로 혈소판풍부혈장(ｐｒｐ)을 활성화하여 조직재생을 유도하는 조성물의 제조방법
PCT/KR2009/006745 WO2011049263A1 (ko) 2009-10-23 2009-11-17 혈소판풍부혈장(ｐｒｐ)을 활성화하여 조직재생을 유도하는 조성물 및 그 제조방법

Publications (1)

Publication Number Publication Date
MX2012004635A true MX2012004635A (es) 2012-07-30

Family

ID=43900476

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012004635A MX2012004635A (es) 2009-10-23 2009-11-17 Composicion para inducir regeneracion de tejido mediante activacion de plasma rico en plaquetas (prp), y metodo para fabricar la misma.

Country Status (18)

Country Link
US (1) US9011929B2 (es)
EP (1) EP2491961B1 (es)
JP (1) JP5550732B2 (es)
KR (1) KR101114712B1 (es)
CN (1) CN102573943B (es)
AU (2) AU2009354233B2 (es)
BR (1) BR112012009560B8 (es)
CA (1) CA2778351C (es)
CY (1) CY1115850T1 (es)
DK (1) DK2491961T3 (es)
ES (1) ES2526759T3 (es)
HR (1) HRP20141098T1 (es)
MX (1) MX2012004635A (es)
PL (1) PL2491961T3 (es)
PT (1) PT2491961E (es)
SI (1) SI2491961T1 (es)
SM (1) SMT201400189B (es)
WO (1) WO2011049263A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2442242B1 (es) * 2012-08-09 2014-11-25 Biotechnology Institute, I Mas D, S.L. Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación.
US10493134B2 (en) 2013-03-21 2019-12-03 Collplant Ltd. Compositions comprising collagen and PRP for tissue regeneration
KR101495449B1 (ko) * 2013-11-12 2015-02-23 전북대학교산학협력단 혈소판 패치의 제조 방법
US10421956B2 (en) 2014-01-17 2019-09-24 General Electric Company Electric pulse generation systems using capacitive coupling
US9452199B2 (en) 2014-01-17 2016-09-27 General Electric Company Platelet activation and growth factor release using electric pulses
US9708597B2 (en) * 2014-01-17 2017-07-18 General Electric Company Electric pulse generation systems using capacitive coupling
CN104587525A (zh) * 2014-12-19 2015-05-06 深圳中元生物科技有限公司 包含血小板及透明质酸的支架及其制备方法
JP6875619B2 (ja) * 2015-02-26 2021-05-26 株式会社細胞応用技術研究所 多血小板血漿の保存方法
JP6731004B2 (ja) * 2015-07-02 2020-07-29 アースレックス インコーポレイテッド 富化体液の調製のための方法および装置
KR20170006820A (ko) 2015-07-10 2017-01-18 주식회사 글로원 혈소판 농축 방법 및 이를 위한 농축기구
WO2017082441A1 (ko) * 2015-11-13 2017-05-18 중부대학교 산학협력단 활성화된 혈소판 풍부 혈장을 유효성분으로 포함하는 동물의 창상 치료용 수의학적 조성물
US10633645B2 (en) * 2015-12-30 2020-04-28 General Electric Company Calcium controlled activation of platelets via electrical stimulation
WO2018078586A1 (en) * 2016-10-27 2018-05-03 Association For The Advancement Of Tissue Engineering And Cell Based Technologies & Therapies A4Tec - Associação Blood derivatives composite material, methods of production and uses thereof
JP7333272B2 (ja) 2017-01-11 2023-08-24 スパイナルサイト， エルエルシー 線維芽細胞治療活性を増強する方法
CN108619497A (zh) * 2017-03-23 2018-10-09 黄丽伟 一种可以促进皮肤胶原再生的组合物及其制备方法和应用
CN107349468B (zh) * 2017-07-02 2020-12-04 江西瑞济生物工程技术股份有限公司 一种羊膜干细胞凝胶及其制备方法和应用
TW201936627A (zh) * 2018-02-26 2019-09-16 鄭本岡 具有高活化細胞因子的血清之備製方法
US10968423B2 (en) 2018-02-26 2021-04-06 General Electric Company System and method for electric pulse based activation of biological samples
CN109513045B (zh) * 2018-11-20 2021-01-15 温州生物材料与工程研究所 具有双层不同内部孔径结构的蛋白基水凝胶及其制备方法
CN111249527A (zh) * 2018-12-03 2020-06-09 陕西佰傲再生医学有限公司 一种富血小板血浆的软组织填充剂及其制备方法
CN114007650A (zh) * 2019-05-24 2022-02-01 诺欧生物有限责任公司 光活化的血液制品和用于制造和使用其的方法和设备
CN110478531A (zh) * 2019-08-02 2019-11-22 中南大学湘雅医院 一种富血小板血浆组织工程支架及其制备方法
CN111110915A (zh) * 2020-02-28 2020-05-08 珠海中信大有科技有限公司 用于构建肌骨组织的自体生长因子补片的制作方法及应用
IT202000024385A1 (it) * 2020-10-15 2022-04-15 Biomedical Res Srl Composizione a base di concentrati piastrinici autologhi e di una miscela di fattori biologici isolata dal colostro per l’uso nel trattamento di condizioni che richiedono la riparazione e la rigenerazione tessutale
CN113244458B (zh) * 2021-05-08 2022-07-08 康膝生物医疗(深圳)有限公司 一种用于修复关节软骨损伤的复合材料及其制备方法
CN113577387A (zh) * 2021-06-09 2021-11-02 康膝生物医疗(深圳)有限公司 一种复合prp和胶原蛋白的温敏水凝胶制备方法及应用
CN114288472A (zh) * 2021-12-07 2022-04-08 武汉亚洲生物材料有限公司 一种基于富血小板血浆的人工骨修复材料及制备方法
WO2023196787A2 (en) * 2022-04-04 2023-10-12 Vascudyne, Inc. Improved constructed tissue
CN115400270A (zh) * 2022-09-08 2022-11-29 南开大学 缓释富血小板血浆的复合支架材料及其制备方法与应用
WO2026018855A1 (ja) * 2024-07-18 2026-01-22 株式会社AdipoSeeds 血小板の機能を評価する方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2295247C (en) * 1997-06-18 2009-05-26 Cohesion Technologies, Inc. Compositions containing thrombin and microfibrillar collagen
US6322785B1 (en) * 1999-03-02 2001-11-27 Natrex Technologies Methods and compositions for bone graft implants
KR20020012170A (ko) * 1999-04-02 2002-02-15 추후제출 폴리산과 폴리에테르의 조성물 및 이들을 유착 방지에이용하는 방법
DE60117984T8 (de) 2000-06-29 2007-06-14 Bio Syntech Canada Inc., Laval Zusammensetzung und verfahren zur reparatur und regenerierung von knorpel und anderen geweben
DE10360628A1 (de) * 2003-12-19 2005-07-21 Dade Behring Marburg Gmbh Kontrollplasma für Thrombinaktivitätstests
WO2006129703A1 (ja) * 2005-05-31 2006-12-07 Kurume University 活性化部分トロンボプラスチン時間の検査方法
US8052969B2 (en) * 2006-12-28 2011-11-08 Arthrex, Inc. Method of making plasma enriched with platelets using a double syringe system where the second sytringe is within the first syringe and use thereof
ES2333498B1 (es) 2007-08-02 2011-01-10 Biotechnology Institute, I Mas D, S.L. Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto.

Also Published As

Publication number Publication date
CN102573943B (zh) 2015-04-08
PT2491961E (pt) 2014-11-14
CY1115850T1 (el) 2017-01-25
CA2778351A1 (en) 2011-04-28
BR112012009560B8 (pt) 2021-06-22
DK2491961T3 (en) 2014-12-01
BR112012009560B1 (pt) 2021-03-09
SMT201400189B (it) 2015-01-15
US9011929B2 (en) 2015-04-21
EP2491961A4 (en) 2013-09-04
AU2009354233B2 (en) 2014-08-28
JP2013508066A (ja) 2013-03-07
US20120201897A1 (en) 2012-08-09
ES2526759T3 (es) 2015-01-15
EP2491961B1 (en) 2014-10-01
HRP20141098T1 (hr) 2015-02-13
JP5550732B2 (ja) 2014-07-16
BR112012009560A2 (pt) 2020-11-17
CN102573943A (zh) 2012-07-11
SI2491961T1 (sl) 2015-01-30
KR20110044615A (ko) 2011-04-29
WO2011049263A1 (ko) 2011-04-28
KR101114712B1 (ko) 2012-02-29
AU2009354233A1 (en) 2012-06-07
AU2014210601A1 (en) 2014-08-28
EP2491961A1 (en) 2012-08-29
CA2778351C (en) 2015-06-09
PL2491961T3 (pl) 2015-03-31

Similar Documents

Publication Publication Date Title
MX2012004635A (es) Composicion para inducir regeneracion de tejido mediante activacion de plasma rico en plaquetas (prp), y metodo para fabricar la misma.
AR067794A1 (es) Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros y el metodo de preparacion del compuesto
EA201170345A1 (ru) Антисмысловые олигонуклеотиды против фактора роста соединительной ткани и способы их применения
DE502007002101D1 (de) Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen
MX2009001323A (es) Aposito solido para tratar tejido herido.
EA201691260A1 (ru) ВАРИАНТЫ, ПРОИСХОДЯЩИЕ ИЗ ActRIIB, И ИХ ПРИМЕНЕНИЕ
WO2012170805A3 (en) Instruments and devices for subchondral joint repair
WO2014045124A3 (en) Instruments for controlled delivery of injectable materials into bone
RU2013132566A (ru) Терапевтическое средство от грыжи межпозвоночного диска
MX2012000504A (es) Proceso para remover factores de crecimiento de las plaquetas.
EA201300988A1 (ru) Мягкая фармацевтическая композиция на водной основе, содержащая тапентадол
WO2009066283A3 (en) Calcium-mediated effects of coral and methods of use thereof
PH12016500828A1 (en) (aza) pyridopyrazolopyrimidinones and indazolopyrimidinones as inhibitors of fibrinolysis
WO2017200659A3 (en) A method to enhance wound healing using silk-derived protein
WO2014053906A8 (en) The application of stem cells in the orthodontic maxillary expansion
EA201591793A1 (ru) Лактамные соединения в качестве селективных агонистов ep4-рецепторов для применения при лечении опосредованных ep4 заболеваний и состояний
WO2012053776A3 (ko) 히알루론산계 화합물, 그 제조방법 및 용도
WO2014061025A3 (en) Films, kits and methods for enhancing tissue treatment by plasma welding
EA201200028A1 (ru) Альфа-1 мультимеры hla-g и их фармацевтическое применение
WO2011093647A3 (en) Genes implicated in osteoarthritis and use thereof
UA33098U (ru) Способ лечения переломов скулового комплекса с дефектами слизистой оболочки верхнечелюстной пазухи
WO2008102150A3 (en) Composition for combating epistaxis
MD37Z (ro) Metodă de tratament al pseudartrozei
UA108813C2 (uk) Спосіб виготовлення біоматеріалу з кісткової тканини
EA201691703A1 (ru) Новые композиции для лечения механических повреждений нервов

Legal Events

Date Code Title Description
FG Grant or registration